Evidence map›Paper›PMID 39219120›Full record

ArticleCurrent pharmaceutical design2024

Evaluation of the Hypoglycemic and Hypolipidemic Potential of Extract Fraction of

Sheheryar Hussain, Farzana Gul Jan, Gul Jan, Muhammad Irfan, Muhammad Musa, Shahid Rahman, Niaz Ali, Muhammad Hamayun, Abdulwahed Fahad Alrefai, Mikhlid H Almutairi and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Current pharmaceutical design, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sheheryar HussainDepartment of Botany, Abdul Wali Khan University, Mardan, Pakistan.
Farzana Gul JanDepartment of Botany, Abdul Wali Khan University, Mardan, Pakistan.
Gul JanDepartment of Botany, Abdul Wali Khan University, Mardan, Pakistan.
Muhammad IrfanDepartment of Botany, Abdul Wali Khan University, Mardan, Pakistan.
Muhammad MusaDepartment of Botany, Abdul Wali Khan University, Mardan, Pakistan.
Shahid RahmanDepartment of Botany, Abdul Wali Khan University, Mardan, Pakistan.
Niaz AliDepartment of Botany, University of Hazara, Mansehra, Pakistan.
Muhammad HamayunDepartment of Botany, Abdul Wali Khan University, Mardan, Pakistan.
Abdulwahed Fahad AlrefaiDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Mikhlid H AlmutairiDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Rafia AzmatDepartment of Chemistry, University of Karachi, Karachi, Pakistan.
Sajid AliDepartment of Horticulture and Life Science, Yeungnam University, Gyeongsan, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe discovery and development of new phytomedicines can be greatly aided by plants because of their tremendous therapeutic benefits, efficiency, cost-effectiveness, lack of side effects, and cheaper therapies. In this regard,

aimFor this purpose, the present study aimed to evaluate crude methanolic extract and various fractions of

methodsThe hypoglycemic and hypolipidemic activity was evaluated in Swiss male Albino mice by administering an oral dose of 150-300 mg/kg of Q. baloot extracts in alloxan induced diabetic mice for 14 days.

resultsThe results revealed that crude methanolic extract at a dose of 300 mg/kg exhibited a significant reduction in the blood glucose level (198.50 ± 1.99 mg/dl) at day 14 and the same treatment significantly increased the body weight (31.26 ± 0.27 g) at day 14 in comparison to the control group. Moreover, the biochemical parameters were investigated which presented an increase in high-density lipids (HDL) (30.33 ± 0.33 mg/dl), whereas low-density lipids (LDL) showed a significant decrease (105.66 ± 0.26 mg/dl). Additionally, triglyceride levels 104.83 ± 0.70 mg/dl, and total cholesterol 185.50 ± 0.76 mg/dl are significantly decreased. In serum biochemical analysis creatinine and hepatic enzyme markers, like serum glutamate pyruvate transaminase (32.00 ± 0.36 U/mg), serum glutamate oxaloacetate transaminase (34.33 ± 0.61 U/mg), and alkaline phosphatase (157.00 ± 0.73 U/mg), were significantly reduced by the crude methanolic extract at a dose of 300 mg/kg as compared to the control group. The antioxidant enzymes like Superoxide dismutase (4.57 ± 0.011), peroxidases dismutase (6.53 ± 0.014, and catalase (8.38 ± 0.014) at a dosage of 300 mg/kg of methanolic extract exhibited a significant increase. The histopathological study of the diabetic heart, liver, and pancreas showed substantial restoration of damaged tissues in the methanolic extract 150 and 300 mg/kg treated group, which supports the effectiveness of Q. baloot seeds. The gas chromatography-mass spectrometry analysis of methanolic extract identified 10 antidiabetic active compounds in the Q. baloot seeds, validating the antihyperglycemic activity. Thus, methanolic crude extract at the doses 150 and 300 mg/kg of Q. baloot showed significant antihyperlipidemic and antihyperglycemic activities, which validate the folkloric utilization of Q. baloot as a remedy in diabetes.

conclusionIn conclusion, the 300 mg/kg methanolic extract of Q. baloot has notable hypoglycemic and hypolipidemic potential, supporting the plant's traditional medicinal usage in the treatment of diabetes and its complications. Further studies are needed for the purification, characterization, and structural clarification of bioactive compounds.

Indexed as

AlloxanDiabetes Mellitus, ExperimentalHypoglycemic AgentsHypolipidemic AgentsPlant ExtractsQuercusSeedsAnimalsBlood GlucoseDose-Response Relationship, DrugMaleMiceAlloxanBlood GlucoseHypoglycemic AgentsHypolipidemic AgentsPlant ExtractsAntidiabeticantioxidantdiabetes mellitus.folkloric medicinemedicinal plantQ. balootseeds

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.